Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C

被引：21
|
作者：
Tassaneeyakul, W [1 ]
Srimarthpirom, S
Reungjui, S
Chansung, K
Romphurk, A
Tassaneeyakul, W [1 ]
机构：
[1] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, Dept Med, Khon Kaen 40002, Thailand
[3] Khon Kaen Univ, Fac Med, Ctr Blood Transfus, Khon Kaen 40002, Thailand
[4] Khon Kaen Univ, Fac Pharmaceut Sci, Dept Toxicol, Khon Kaen 40002, Thailand
来源：
TRANSPLANTATION | 2003年 / 76卷 / 01期
关键词：
D O I：
10.1097/01.TP.0000070521.22024.F1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：265 / 266
页数：2
相关论文
共 17 条
  • [1] Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand
    Vannaprasaht, Suda
    Angsuthum, Susothorn
    Avihingsanon, Yingyos
    Sirivongs, Dhavee
    Pongskul, Cholatip
    Makarawate, Pattarapong
    Praditpornsilpa, Kearkiat
    Tassaneeyakul, Wongwiwat
    Tassaneeyakul, Wichittra
    CLINICAL THERAPEUTICS, 2009, 31 (07) : 1524 - 1533
  • [2] Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism
    Boonsrirat, U.
    Angsuthum, S.
    Vannaprasaht, S.
    Konapurivijit, J.
    Hirankarn, N.
    Tassaneeyakul, W.
    Avihingsanon, Y.
    LUPUS, 2008, 17 (02) : 132 - 134
  • [3] REVERSIBLE AZATHIOPRINE-INDUCED ERYTHROCYTE APLASIA IN A RENAL-TRANSPLANT RECIPIENT
    HOGGE, DE
    WILSON, DR
    SHUMAK, KH
    CATTRAN, DC
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 126 (05) : 512 - 513
  • [4] AZATHIOPRINE-INDUCED PURE RED-BLOOD-CELL APLASIA IN A RENAL-TRANSPLANT RECIPIENT
    AGARWAL, SK
    MITTAL, D
    TIWARI, SC
    DASH, SC
    SAXENA, S
    SAXENA, R
    MEHTA, SN
    NEPHRON, 1993, 63 (04): : 471 - 471
  • [5] AZATHIOPRINE-INDUCED INTERSTITIAL PNEUMONITIS IN RENAL-TRANSPLANT RECIPIENTS
    BEDROSSIAN, CWM
    CONKLIN, RH
    KAHAN, B
    SUSSMAN, J
    LABORATORY INVESTIGATION, 1982, 46 (01) : A9 - A9
  • [6] AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN THIOPURINE METHYLTRANSFERASE DEFICIENT HEART-TRANSPLANT RECIPIENT
    MCLEOD, HL
    MILLER, DR
    EVANS, WE
    LANCET, 1993, 341 (8853): : 1151 - 1151
  • [7] AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN THIOPURINE METHYLTRANSFERASE DEFICIENT HEART-TRANSPLANT RECIPIENT
    SCHUTZ, E
    GUMMERT, J
    MOHR, F
    OELLERICH, M
    LANCET, 1993, 341 (8842): : 436 - 436
  • [8] Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism
    Ben Salem, Chaker
    Ben Salah, Lynda
    Belajouza, Colandane
    Bouraoui, Kamel
    PHARMACY WORLD & SCIENCE, 2010, 32 (06): : 701 - 703
  • [9] Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism
    Chaker Ben Salem
    Lynda Ben Salah
    Colandane Belajouza
    Kamel Bouraoui
    Pharmacy World & Science, 2010, 32 : 701 - 703
  • [10] Severe azathioprine-induced mye otoxicity in a kidney transplant patient with thiopurine S-methyltransferasedeficient genotype (TPMT*3A/*3C)
    Kurzawski, M
    Dziewanowski, K
    Ciechanowski, K
    Drozdzik, M
    TRANSPLANT INTERNATIONAL, 2005, 18 (05) : 623 - 625
12